We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$97.3B
AUM Growth
+$5.53B
Cap. Flow
+$1.37B
Cap. Flow %
1.41%
Top 10 Hldgs %
9.68%
Holding
3,734
New
508
Increased
1,623
Reduced
1,169
Closed
410

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$707M
2
JNJ icon
Johnson & Johnson
JNJ
+$396M
3
AMZN icon
Amazon
AMZN
+$312M
4
WMT icon
Walmart Inc
WMT
+$285M
5
ISRG icon
Intuitive Surgical
ISRG
+$262M

Sector Composition

Rank Sector Weight
1 Healthcare 17.73%
2 Technology 14.98%
3 Financials 10.9%
4 Consumer Discretionary 8.96%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNAM
3226
DELISTED
Unico American Corp
UNAM
$123K ﹤0.01%
17,400
BDR
3227
DELISTED
Blonder Tongue Laboratories Inc
BDR
$121K ﹤0.01%
96,558
+6,758
+8% +$8.73K
RGLS
3228
DELISTED
Regulus Therapeutics
RGLS
$118K ﹤0.01%
4,963
+3,963
+396% +$131K
TOVX icon
3229
Theriva Biologics
TOVX
$9.64M
$118K ﹤0.01%
+181
New +$200K
EMITF
3230
DELISTED
Elbit Imaging Ltd
EMITF
$117K ﹤0.01%
51,713
+600
+1% +$1.36K
ELTK icon
3231
Eltek
ELTK
$55.6M
$115K ﹤0.01%
33,801
+100
+0.3% +$379
VTSI icon
3232
VirTra
VTSI
$35.7M
$113K ﹤0.01%
+21,202
New +$108K
DARE icon
3233
Dare Bioscience
DARE
$18.6M
$111K ﹤0.01%
9,512
+4,175
+78% +$56.2K
PANL icon
3234
Pangaea Logistics
PANL
$493M
$111K ﹤0.01%
+31,600
New +$104K
KZIA
3235
Kazia Therapeutics
KZIA
$146M
$109K ﹤0.01%
687
EMX
3236
DELISTED
EMX Royalty
EMX
$108K ﹤0.01%
88,126
-17,274
-16% -$19.9K
VERU icon
3237
Veru
VERU
$35.6M
$108K ﹤0.01%
7,610
-4,470
-37% -$87.5K
AMS icon
3238
American Shared Hospital Services
AMS
$9.67M
$105K ﹤0.01%
29,900
-4,700
-14% -$14K
GCAP
3239
DELISTED
Gain Capital Holdings, Inc.
GCAP
$105K ﹤0.01%
+16,200
New +$117K
XPL icon
3240
Solitario Resources
XPL
$67.5M
$103K ﹤0.01%
294,115
+50,832
+21% +$19.8K
RSLS
3241
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
$101K ﹤0.01%
+16,341
New +$1.41M
CODA icon
3242
Coda Octopus Group
CODA
$115M
$100K ﹤0.01%
16,600
+3,115
+23% +$14.6K
CPHI icon
3243
China Pharma Holdings
CPHI
$52.7M
$100K ﹤0.01%
982
-36
-4% -$4.23K
CTXR icon
3244
Citius Pharmaceuticals
CTXR
$17.4M
$100K ﹤0.01%
+2,333
New +$111K
OPK icon
3245
Opko Health
OPK
$993M
$100K ﹤0.01%
+29,043
New +$154K
TYME
3246
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$100K ﹤0.01%
+35,900
New +$93.6K
LVO icon
3247
LiveOne
LVO
$61.6M
$99K ﹤0.01%
+2,530
New +$123K
ASM
3248
Avino Silver & Gold Mines
ASM
$969M
$94K ﹤0.01%
+150,600
New +$152K
SOFO
3249
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
$91K ﹤0.01%
56,719
+2,500
+5% +$4.9K
GMO
3250
DELISTED
General Moly, Inc.
GMO
$87K ﹤0.01%
235,351
+31,246
+15% +$12.2K

Similar funds

Renaissance Technologies's Q3 2018 Portfolio in Review

As of Q3 2018, Renaissance Technologies held 3,734 positions worth $97.3B, up 6% from $91.7B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Renaissance Technologies's Q3 2018 filing shows 508 new, 1,623 increased, 1,169 reduced and 410 closed positions. Its largest new stake was JPMorgan Chase: 2,054,913 shares worth $232M. The largest sale was Apple, an estimated $707M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • Renaissance Technologies's largest Q3 2018 buy was JPMorgan Chase: 2,054,913 shares worth $232M.
  • Renaissance Technologies added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $327M increase.
  • Renaissance Technologies's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $396M.
  • Renaissance Technologies fully exited Apple in Q3 2018, selling an estimated $707M.
  • Renaissance Technologies's ten largest holdings make up 9.7% of its $97.3B portfolio in Q3 2018.
  • Renaissance Technologies opened 508 new positions and closed 410 in Q3 2018.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $97.3B.

Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.